Kiora Pharmaceuticals Inc Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

Kiora Pharmaceuticals Inc capital reinvestment ratio. Kiora Pharmaceuticals Inc (KPRX) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($920.06K) in capital expenditures ($3.00). Check Kiora Pharmaceuticals Inc (KPRX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$920.06K
USD

Capital Expenditures

$3.00
USD

Data as of

Sep 2024
Most recent filing

Capital Reinvestment Ratio of Kiora Pharmaceuticals Inc (2024–2024)

Capital reinvestment ratio of Kiora Pharmaceuticals Inc from 2024 to 2024. This chart tracks Kiora Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore KPRX shareholders equity momentum to track the company's year-over-year net asset growth rate.

Kiora Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2024–2024)

Kiora Pharmaceuticals Inc capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see Kiora Pharmaceuticals Inc (KPRX) cash flow conversion.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.00x $8.56 Million $6.26K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow